These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7494275)

  • 21. Hierarchic T-cell help to non-linked B-cell epitopes.
    Brons NH; Blaich A; Wiesmüller KH; Schneider F; Jung G; Muller CP
    Scand J Immunol; 1996 Nov; 44(5):478-84. PubMed ID: 8947599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of antibody response to synthetic peptides derived from the fusion protein of measles virus.
    Meqdam M; Mostratos A
    New Microbiol; 1999 Jan; 22(1):19-25. PubMed ID: 10190113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
    El Kasmi KC; Theisen D; Brons NH; Muller CP
    Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper.
    Chandran D; Shahana PV; Rani GS; Sugumar P; Shankar CR; Srinivasan VA
    Vaccine; 2009 Dec; 28(1):132-9. PubMed ID: 19818723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
    Beauverger P; Chadwick J; Buckland R; Wild TF
    Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
    Galletti R; Beauverger P; Wild TF
    Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein.
    Zhang X; Wallace OL; Domi A; Wright KJ; Driscoll J; Anzala O; Sanders EJ; Kamali A; Karita E; Allen S; Fast P; Gilmour J; Price MA; Parks CL
    Virology; 2015 Aug; 482():218-24. PubMed ID: 25880113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.
    Sheshberadaran H; Norrby E; McCullough KC; Carpenter WC; Orvell C
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1381-92. PubMed ID: 2425047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides.
    Partidos CD; Salani FB; Ripley J; Steward MW
    Vaccine; 1999 Sep; 18(3-4):321-4. PubMed ID: 10506658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus.
    Steward MW
    Biologicals; 2001; 29(3-4):215-9. PubMed ID: 11851318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective role of human antibody to the fusion protein of measles virus.
    Sato TA; Kohama T; Sugiura A
    Microbiol Immunol; 1989; 33(7):601-7. PubMed ID: 2671610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper.
    Appel MJ; Shek WR; Shesberadaran H; Norrby E
    Arch Virol; 1984; 82(1-2):73-82. PubMed ID: 6497659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus.
    Ghosh S; Walker J; Jackson DC
    Immunology; 2001 Sep; 104(1):58-66. PubMed ID: 11576221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides.
    Obeid OE; Partidos CD; Steward MW
    Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological relationships between phocid and canine distemper virus studied with monoclonal antibodies.
    Orvell C; Blixenkrone-Möller M; Svansson V; Have P
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2085-92. PubMed ID: 1698923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
    de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The response to measles and distemper virus in immuno-suppressed and normal dogs.
    Slater EA
    J Am Vet Med Assoc; 1970 Jun; 156(12):1762-6. PubMed ID: 5422526
    [No Abstract]   [Full Text] [Related]  

  • 39. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.
    Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
    Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crossreactivity of mimotopes and peptide homologues of a sequential epitope with a monoclonal antibody does not predict crossreactive immunogenicity.
    El Kasmi KC; Deroo S; Theisen DM; Brons NH; Muller CP
    Vaccine; 1999 Sep; 18(3-4):284-90. PubMed ID: 10506653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.